Oracle and M42 Collaborate to Enhance Healthcare with Genomic Insights

Oracle Health has announced a strategic partnership with M42, a leader in global health innovation, to harness the power of genomics in healthcare. This collaboration aims to advance the delivery of precision medicine through the integration of pharmacogenomic data at the point of care, according to Oracle.

Advancing Precision Medicine

The partnership will focus on creating unified, longitudinal patient records accessible throughout the UAE. This initiative will see Oracle Health and M42 incorporating data from the Emirati Genome Program directly into electronic health records (EHR). This integration aims to support personalized, data-driven healthcare by enabling pharmacogenomic recommendations for patients, thereby optimizing treatment outcomes and improving overall healthcare delivery.

Empowering Clinicians and Patients

Dimitris Moulavasilis, Group CEO at M42, emphasized the transformative potential of this collaboration, stating that it will empower clinicians with actionable insights and allow for proactive, personalized care. He highlighted the goal of shaping a healthier future for communities across the UAE by making healthcare predictive and accessible.

Dr. Fahed Al Marzooqi, CEO of M42’s Integrated Health Solutions platform, noted the importance of informing physicians at the point of prescribing about genetic compatibility with medications. This capability is expected to enhance the effectiveness of prescribed treatments and expedite patient recovery.

Strategic Objectives and Benefits

The collaboration, formalized during a signing ceremony, aims to revolutionize healthcare delivery both nationally and beyond. Key objectives include:

• Proactive Healthcare: Utilizing AI and advanced analytics to shift the focus from reactive care to preventive measures, thereby promoting longevity and well-being.
• Precision Medicine at Scale: Leveraging genomic data to provide tailored treatments, reinforcing the UAE’s leadership in personalized healthcare.
• Nationwide Access: Developing a secure, scalable patient portal for seamless access to health records, enhancing care coordination and patient engagement.

Enhancing Treatment Efficacy

Seema Verma, Executive Vice President at Oracle Health and Life Sciences, highlighted the role of pharmacogenomic insights in delivering more personalized care. By tailoring medications to a patient’s genetic profile, the initiative aims to enhance treatment efficacy, improve preventive care, and reduce the waste associated with ineffective prescriptions. This aligns with the UAE’s vision of pioneering health innovation and delivering exceptional, patient-centric care.

The Emirati Genome Program, one of the world’s largest genomic initiatives, plays a crucial role in this endeavor by advancing disease prevention and enabling early diagnosis and personalized treatments based on local genetic profiles.

Image source: Shutterstock